ScienceGuardians

ScienceGuardians

Did You Know?

ScienceGuardians serves the community for free

Role of monocarboxylate transporters in cancer immunology and their therapeutic potential

Authors: Ferdos Faghihkhorasani,Mona Moosavi,Al‐Hasnawi Rasool Riyadh Abdulwahid,Mohammed Kavei,Soroush Karimi,Mahshid Seyed Karimi,Payam Vezvaei,Mahsa Manafi Varkiani,Amir Reza Aref,Nasim Ebrahimi
Journal: British Journal of Pharmacology
Publisher: Wiley
Publish date: 2025-7-30
ISSN: 0007-1188 DOI: 10.1111/bph.70110
View on Publisher's Website
Up
0
Down
::

1. Why do Figures 6 and 8 exhibit the unmistakable 3D-rendered characteristics of generative AI, when the methodology explicitly claims they were created using vector/raster tools like Adobe Illustrator and CorelDRAW?
2. Why does Table 2 state that the Garuda motif “Symbolizes the slopes of mountains,” when this is historically and iconographically the meaning of the Meru/Gunungan (mountain) motif, while Garuda represents a mythical bird/eagle?

3. Section 3.2.1 cites literature stating the optimal FGD size is 6-10 participants. Since you had 15 participants, did you conduct one group (violating the rule) or multiple groups (falling below the optimal size)?
4. The text claims the FGD participants identified and elaborated on the motifs in Table 2, yet every entry cites historical literature (e.g., Sunaryo, 2009; Kusrianto, 2013). Did the FGD participants provide these exact citations, or was standard textbook data falsely attributed to the FGD?
5. Why does Figure 4 contain broken arrow logic (e.g., bypassing expert review) and completely omit the “prototyping” phase that is described in the text?
6. The traditional Parang motif (Figure 7) symbolizes unbroken continuity via continuous S-curves. How does replacing this with a highly symmetrical, static 3D dagger and flower in Figure 8 “maintain and potentially deepen” its original philosophical meaning?
7. Why are there absolutely no direct quotes, participant identifiers, or transcript excerpts from the FGDs and in-depth interviews, making the entire findings section read like a secondary literature review?

  • You must be logged in to reply to this topic.